The Board of Directors of Cytek Biosciences, Inc. has authorized a buyback plan on June 6, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.385 USD | +1.60% | 0.00% | -40.24% |
06-12 | Cytek Biosciences to Seek M&A | CI |
06-12 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.24% | 696M | |
+4.70% | 213B | |
+9.03% | 188B | |
+31.09% | 157B | |
+32.81% | 113B | |
+4.52% | 64.85B | |
+21.69% | 55.17B | |
+1.51% | 49.1B | |
-4.85% | 38.83B | |
+1.47% | 35.6B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences, Inc. authorizes a Buyback Plan.